Novo Nordisk Gets CDSCO Panel Nod to Conduct India-Specific PMS Studies on Somapacitan Susmita Roy17 Dec 2025 9:04 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to Novo Nordisk India...
Sun Pharma Agrees to Halt India Sales of Semaglutide After Delhi HC Records Patent Undertaking Susmita Roy11 Dec 2025 4:08 PM ISTNew Delhi: The Delhi High Court on Wednesday recorded a categorical undertaking from Sun Pharma that it will not market or sell its semaglutide...
Novo Nordisk concludes USD 4.7 billion acquisition of Akero Therapeutics Ruchika Sharma10 Dec 2025 1:30 PM ISTDenmark: Novo Nordisk and Akero Therapeutics have announced that Novo Nordisk's acquisition of Akero has been completed.With the completion of...
Semaglutide Patent War: After Dr Reddy's Blow, Novo Nordisk Moves Delhi HC Against Sun Pharma Susmita Roy9 Dec 2025 5:00 PM ISTNew Delhi: In an escalation of India's unfolding GLP-1 patent war, Novo Nordisk has approached the Delhi High Court to restrain Sun Pharmaceutical...
Semaglutide Patent Clash: Delhi HC Denies Novo Nordisk Injunction, Manufacturing by Dr Reddy's to Continue Susmita Roy5 Dec 2025 10:28 PM ISTNew Delhi: In a significant development in the high-stakes patent litigation over diabetes blockbuster Semaglutide, the Delhi High Court has refused...
Amycretin Shows Major HbA1c and Weight Reduction in Phase II Trial Dr. Kamal Kant Kohli29 Nov 2025 12:00 PM ISTA phase II study has reported that type 2 diabetes patients treated with amycretin-a long-acting investigational GLP-1 and amylin receptor...
Novo Nordisk seeks USFDA approval for higher dose of Wegovy injection Ruchika Sharma28 Nov 2025 11:30 AM ISTPlainsboro: Novo Nordisk has announced the submission of a sNDA to the U.S. Food and Drug Administration (FDA) for a higher dose of semaglutide...
CDSCO Panel Reviews Novo Nordisk's PMS Study, Clears Data on Oral Semaglutide Susmita Roy22 Nov 2025 10:50 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) reviewed the Post Marketing Surveillance...
Pfizer files second lawsuit against Metsera, its controlling stockholders, Novo Nordisk Ruchika Sharma4 Nov 2025 12:02 PM ISTNew York: Pfizer has announced that it has filed a second lawsuit against Metsera, its controlling stockholders, and Novo Nordisk A/S in the...
Novo Nordisk submits proposal to acquire Metsera Ruchika Sharma2 Nov 2025 6:00 PM ISTDenmark: Novo Nordisk confirms that it submitted an unsolicited proposal to acquire Metsera, Inc.The acquisition of Metsera, including its early...
Pfizer files lawsuit against Metsera, its Directors and Novo Nordisk for breach of merger agreement Ruchika Sharma2 Nov 2025 2:30 PM ISTNew York: Pfizer has announced that it has filed a lawsuit against Metsera, its Board of Directors, and Novo Nordisk, S.A. in the Delaware Court...
Novo Nordisk gets MHRA nod for Concizumab to prevent bleeding episodes frequency Ruchika Sharma27 Oct 2025 10:30 AM ISTNovo Nordisk has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) for the medicine concizumab (brand name:...
